| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 07/15/2008 | US7399348 Low surface tension surfactants based on amino alcohol and their use |
| 07/10/2008 | WO2008081811A1 Plastic crystal |
| 07/10/2008 | WO2008081477A1 3-aryloxy 3-substituted propanamines |
| 07/10/2008 | WO2008062469A3 Selective tr-beta 1 agonist |
| 07/10/2008 | WO2008059525A3 An improved process for the preparation of venlafaxine and its analogs |
| 07/10/2008 | US20080167498 White crystals characterized by powder x-ray diffraction peaks at 12.8, 20.5, 21.3+-0.2 degrees two-theta; As inhibitor of re-uptake of norepinephrine and serotonin, used as anti-depressants |
| 07/10/2008 | DE102006059215A1 Arylaminsubstituierte Divinylfluorene und ihre Nutzung für elektrofotografische Anwendungen und für OLEDS (Organic Light Emitting Devices) Arylaminsubstituierte Divinylfluorene and their use for electrophotographic applications and for OLEDs (Organic Light Emitting Devices) |
| 07/09/2008 | CN101218203A Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the ss2 adrenergic receptor |
| 07/09/2008 | CN101215241A Method for preparing 1,4-di(2,4-diaminophenoxy)benzene |
| 07/09/2008 | CN101215240A Preparation method for 4,4'-diamino-4''-(4-nitrophenoxy)triphenylmethane |
| 07/08/2008 | US7396954 Alkyl 2-[4-(1-hydroxy-2,2-dialkoxyethyl)-2,5-dimethylphenoxy]acetate, which is an intermediate for preparing alkyl 2-[4-[2-[2-hydroxy-2-(4-hydroxyphenyl)-1-methyethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate |
| 07/08/2008 | US7396367 Double secondary para-phenylenediamine compounds, dye compositions comprising same, and dyeing process using the compositions |
| 07/03/2008 | WO2007107276A3 Process for preparing c7 intermediates and their use in the preparation of n-substituted pyrrole derivatives |
| 07/03/2008 | CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 07/02/2008 | EP1939172A2 Method of obtaining phenyl carbamates |
| 07/02/2008 | EP1937626A1 Novel process |
| 07/02/2008 | EP1593666B1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 07/02/2008 | CN101213199A Compounds for preparing immunological adjuvant |
| 07/02/2008 | CN100398512C Method for preparing (+-)-alpha-[(substituted amino) methyl]-benzene ring substituted group-phenylmethanol type compounds |
| 07/01/2008 | US7393968 Intermediates in producing phenoxyacetic acid derivatives and method of using the same |
| 06/26/2008 | WO2008074227A1 Synthetic ion channels |
| 06/25/2008 | EP1718599A4 Synthesis of sterically hindered secondary aminoether alcohols |
| 06/25/2008 | EP1718598A4 Synthesis of sterically hindered secondary aminoether alcohols from acid anhydride and/or acid halide and sulfur trioxide |
| 06/25/2008 | CN101205192A Method for preparing 1,3-di(4-amino-benzene oxygen) benzene |
| 06/25/2008 | CN101205191A Method for preparing hydrochloric venlafaxine new crystal C |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/19/2008 | US20080146675 Analyzing stability of atomoxetine hydrochloride by determining pH of sample of atomoxetine hydrochloride in aqueous solution; stable atomoxetine hydrochloride contains reduced amount of free hydrogen chloride, such that an aqueous solution has a pH of 4-7; shelf life, purity; attention-deficit disorder |
| 06/19/2008 | US20080146554 Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament |
| 06/19/2008 | DE19859776B4 Verfahren zur Herstellung von Aminen A process for preparing amines |
| 06/19/2008 | CA2672187A1 Acetylene derivatives and their use for binding and imaging amyloid plaques |
| 06/18/2008 | EP1932826A1 Method for producing aminoalcohol derivative having biphenyl group |
| 06/18/2008 | CN101200620A Curable hybrid electron donor compounds containing vinyl ether |
| 06/18/2008 | CN101200432A Method for synthesizing N,N bis(2-hydroxypropyl) aniline series chain extender |
| 06/17/2008 | US7388033 applied to various surfaces, especially metallic vehicle surfaces, wherein the compositions form a protective barrier on the surface and improve the drying rate, protection and shine of the surface |
| 06/17/2008 | US7387845 Monoamino compound and organic luminescence device using the same |
| 06/12/2008 | WO2008069518A1 Pharmaceutical composition for controlling the function of spihngosylphosphorylcholine |
| 06/12/2008 | US20080139795 And halogenated 4-(phenyldiazenyl)phenols; chemical intermediates; pharmaceuticals and agrochemicals |
| 06/11/2008 | EP1930312A1 Fluoroether having terminal alkylamino group and method for producing same |
| 06/11/2008 | EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 06/11/2008 | CN101198582A Polymorphic crystal of 4'-{2-[ (1s, 2r) - 2- hydroxy -2- (4-hydroxyphenyl) -1- methylethylamino] ethoxy} - 3 - isopropyl-3', 5' -dimethylbiphenyl - 4 - carboxylic acid hydrochloride |
| 06/11/2008 | CN101195580A Process for producing 2,2-dual [3-amido-4-(4-nitrophenoxy) phenyl] propane |
| 06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 06/10/2008 | US7384980 Derivatives of 3,3-diphenylpropylamines |
| 06/10/2008 | US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132579 characterized by at least one of an enantiomeric excess of at least about 99.8%; having less than about 1700 ppm of residual C1-C4 alcohol; or having a pH of at least about 4.3 in 1% aqueous solution at room temperature |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/04/2008 | EP1927585A2 Method of obtaining 3,3-diphenylpropylamines |
| 06/04/2008 | CN100391933C Substituted 1-aminobutan-3-01 derivatives |
| 06/03/2008 | US7381813 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 06/03/2008 | US7381422 Mixing cationic surfactant, a polyoxyethylene and polyoxypropylene block copolymer and a polynucleotide at a temperature below the cloud point of said block copolymer to form a mixture; cold filtering the mixture to produce a sterile formulation |
| 05/29/2008 | WO2008062473A1 Process for preparing atomoxetine hydrochloride |
| 05/29/2008 | WO2008062469A2 Selective tr-beta 1 agonist |
| 05/29/2008 | WO2008062138A1 In situ or one-pot method for hydrogenation and reductive amination |
| 05/28/2008 | EP1925613A1 Substituted pyrazolecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agent for agricultural and horticultural use, and use thereof |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | CN101186579A Method for preparing 4,4'-di(4-aminophenoxy)-3,3',5,5'-tetramethylbiphenyl |
| 05/28/2008 | CN100390133C Organic electroluminescent devices |
| 05/27/2008 | US7378519 enantiomerically pure 1S,2S-tramadol hydrochloride by dissolving topiramate and tramadol hydrochloride; cooling; crystallization; filtration; separating the 1S,2S-tramadol hydrochloride from the mother liquor by chromatography or crystallization |
| 05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
| 05/22/2008 | WO2008059525A2 An improved process for the preparation of venlafaxine and its analogs |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1922300A2 Cationic lipids and formulated molecular compositions containing them |
| 05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/15/2008 | WO2008035358A3 Process for preparing dapoxetine |
| 05/15/2008 | WO2008030771A8 Cyclic alkylidene compounds as selective estrogen receptor modulators |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |
| 05/14/2008 | EP1919855A2 Alkylamino alkyloxy (alcohol) monoalkyl ether for acid gas scrubbing process |
| 05/14/2008 | EP1575922B1 Biphenyl derivatives and their use as fungicides |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |
| 05/14/2008 | CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 05/13/2008 | US7371887 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly |
| 05/13/2008 | US7371868 Bactericides; 2-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-1,3,6,2-dioxazaborocane. |
| 05/13/2008 | CA2214894C Substituted dibenz[a,f]azulenes and methods of preparation |
| 05/08/2008 | WO2008054154A1 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same |
| 05/08/2008 | WO2008053652A1 Process for production of hydroxyadamantaneamine |
| 05/08/2008 | US20080108840 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 05/08/2008 | CA2667855A1 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same |
| 05/07/2008 | EP1918261A1 Chemical etching composition for the preparation of 3-d nanostructures |
| 05/07/2008 | EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 05/07/2008 | CN101172954A Compound for electroluminescent organic material and method for producing the same |
| 05/07/2008 | CN100386306C 3-ú¿2-methoxyethoxyú®-propylamine production process |
| 05/06/2008 | US7368609 e.g., N-(1-[3,5-bis(trifluoromethyl)phenyl]ethyl)-N-methyl-N-(1-phenylethyl)amine; intermediates for medicines and agricultural chemicals |
| 05/06/2008 | US7368608 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1,4-benzodioxane derivatives |
| 05/06/2008 | US7368607 Crystallizing toremifene in methanol; crystallizing in acetone, methyl ethyl ketone or ethyl acetate; and optionally forming a salt (e.g., citrate) |
| 05/06/2008 | US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors |
| 05/01/2008 | US20080103316 Reduction of 4-aryl-4-ketobutanoic acid derivatives utilizing ruthenium containing catalysts |
| 04/30/2008 | WO2008053285A1 Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(i) tetrafluoroborate |
| 04/30/2008 | DE102004042418B4 Absorptionsflüssigkeit, deren Verwendung und Verfahren zum Reinigen von Gasen Absorbing liquid, their use and method for cleaning of gases |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives |
| 04/26/2008 | CA2607781A1 Chemical etching composition for the preparation of 3-d nano-structures |
| 04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
| 04/24/2008 | WO2008047382A2 A process for the preparation of 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol |
| 04/24/2008 | WO2008046745A1 Process for the synthesis of aryloxypropylamine and heteroaryloxypropylamine |
| 04/24/2008 | WO2008046598A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/24/2008 | US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride |
| 04/24/2008 | DE102007006136A1 Z-Stilben-Derivate und das Arzneimittel davon Z-stilbene derivatives and pharmaceutical compositions thereof |
| 04/24/2008 | CA2665376A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |